Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines

On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO)

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The aim of this study was to update the clinical practice guidelines for the use of basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis (OM). Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added to the database used to develop the 2013 MASCC/ISOO clinical practice guidelines. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, No guideline possible. Results: A total of 17 new papers across six interventions were examined and merged with a previous database. Based on the literature, the following guidelines were possible. The panel suggests that the implementation of multi-agent combination oral care protocols is beneficial for the prevention of OM during chemotherapy, head and neck (H&N) radiation therapy (RT), and hematopoietic stem cell transplantation (Level of Evidence III). The panel suggests that chlorhexidine not be used to prevent OM in patients undergoing H&N RT (Level of Evidence III). No guideline was possible for professional oral care, patient education, saline, and sodium bicarbonate, and expert opinion complemented these guidelines. Conclusions: The evidence supports the use of multi-agent combination oral care protocols in the specific populations listed above. Additional well-designed research is needed on the other BOC interventions prior to guideline formulation.

Original languageEnglish (US)
Pages (from-to)3949-3967
Number of pages19
JournalSupportive Care in Cancer
Volume27
Issue number10
DOIs
StatePublished - Oct 1 2019

Fingerprint

Stomatitis
Practice Guidelines
Guidelines
Neoplasms
Radiotherapy
Databases
Mucositis
Sodium Bicarbonate
Chlorhexidine
Medical Oncology
Hematopoietic Stem Cell Transplantation
Expert Testimony
Patient Education
Neck
Head
Drug Therapy
Therapeutics
Research
Population

Keywords

  • Basic oral care
  • Cancer
  • Chlorhexidine
  • Dental care
  • Guidelines
  • Oral mucositis
  • Patient education
  • Saline
  • Sodium bicarbonate

ASJC Scopus subject areas

  • Oncology

Cite this

On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) (2019). Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 27(10), 3949-3967. https://doi.org/10.1007/s00520-019-04848-4

Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. / On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO).

In: Supportive Care in Cancer, Vol. 27, No. 10, 01.10.2019, p. 3949-3967.

Research output: Contribution to journalArticle

On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) 2019, 'Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines', Supportive Care in Cancer, vol. 27, no. 10, pp. 3949-3967. https://doi.org/10.1007/s00520-019-04848-4
On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer. 2019 Oct 1;27(10):3949-3967. https://doi.org/10.1007/s00520-019-04848-4
On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). / Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. In: Supportive Care in Cancer. 2019 ; Vol. 27, No. 10. pp. 3949-3967.
@article{7ea09b1becf2469eab14cea0497c6457,
title = "Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines",
abstract = "Purpose: The aim of this study was to update the clinical practice guidelines for the use of basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis (OM). Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added to the database used to develop the 2013 MASCC/ISOO clinical practice guidelines. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, No guideline possible. Results: A total of 17 new papers across six interventions were examined and merged with a previous database. Based on the literature, the following guidelines were possible. The panel suggests that the implementation of multi-agent combination oral care protocols is beneficial for the prevention of OM during chemotherapy, head and neck (H&N) radiation therapy (RT), and hematopoietic stem cell transplantation (Level of Evidence III). The panel suggests that chlorhexidine not be used to prevent OM in patients undergoing H&N RT (Level of Evidence III). No guideline was possible for professional oral care, patient education, saline, and sodium bicarbonate, and expert opinion complemented these guidelines. Conclusions: The evidence supports the use of multi-agent combination oral care protocols in the specific populations listed above. Additional well-designed research is needed on the other BOC interventions prior to guideline formulation.",
keywords = "Basic oral care, Cancer, Chlorhexidine, Dental care, Guidelines, Oral mucositis, Patient education, Saline, Sodium bicarbonate",
author = "{On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO)} and Hong, {Catherine H.L.} and Gueiros, {Luiz Alcino} and Fulton, {Janet S.} and Cheng, {Karis Kin Fong} and Abhishek Kandwal and Dimitra Galiti and Fall-Dickson, {Jane M.} and Jorgen Johansen and Suzanne Ameringer and Tomoko Kataoka and Dianna Weikel and June Eilers and Vinasha Ranna and Anusha Vaddi and Lalla, {Rajesh V.} and Paolo Bossi and Sharon Elad",
year = "2019",
month = "10",
day = "1",
doi = "10.1007/s00520-019-04848-4",
language = "English (US)",
volume = "27",
pages = "3949--3967",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines

AU - On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO)

AU - Hong, Catherine H.L.

AU - Gueiros, Luiz Alcino

AU - Fulton, Janet S.

AU - Cheng, Karis Kin Fong

AU - Kandwal, Abhishek

AU - Galiti, Dimitra

AU - Fall-Dickson, Jane M.

AU - Johansen, Jorgen

AU - Ameringer, Suzanne

AU - Kataoka, Tomoko

AU - Weikel, Dianna

AU - Eilers, June

AU - Ranna, Vinasha

AU - Vaddi, Anusha

AU - Lalla, Rajesh V.

AU - Bossi, Paolo

AU - Elad, Sharon

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Purpose: The aim of this study was to update the clinical practice guidelines for the use of basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis (OM). Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added to the database used to develop the 2013 MASCC/ISOO clinical practice guidelines. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, No guideline possible. Results: A total of 17 new papers across six interventions were examined and merged with a previous database. Based on the literature, the following guidelines were possible. The panel suggests that the implementation of multi-agent combination oral care protocols is beneficial for the prevention of OM during chemotherapy, head and neck (H&N) radiation therapy (RT), and hematopoietic stem cell transplantation (Level of Evidence III). The panel suggests that chlorhexidine not be used to prevent OM in patients undergoing H&N RT (Level of Evidence III). No guideline was possible for professional oral care, patient education, saline, and sodium bicarbonate, and expert opinion complemented these guidelines. Conclusions: The evidence supports the use of multi-agent combination oral care protocols in the specific populations listed above. Additional well-designed research is needed on the other BOC interventions prior to guideline formulation.

AB - Purpose: The aim of this study was to update the clinical practice guidelines for the use of basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis (OM). Methods: A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention in each cancer treatment setting was assigned an evidence level. The findings were added to the database used to develop the 2013 MASCC/ISOO clinical practice guidelines. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, No guideline possible. Results: A total of 17 new papers across six interventions were examined and merged with a previous database. Based on the literature, the following guidelines were possible. The panel suggests that the implementation of multi-agent combination oral care protocols is beneficial for the prevention of OM during chemotherapy, head and neck (H&N) radiation therapy (RT), and hematopoietic stem cell transplantation (Level of Evidence III). The panel suggests that chlorhexidine not be used to prevent OM in patients undergoing H&N RT (Level of Evidence III). No guideline was possible for professional oral care, patient education, saline, and sodium bicarbonate, and expert opinion complemented these guidelines. Conclusions: The evidence supports the use of multi-agent combination oral care protocols in the specific populations listed above. Additional well-designed research is needed on the other BOC interventions prior to guideline formulation.

KW - Basic oral care

KW - Cancer

KW - Chlorhexidine

KW - Dental care

KW - Guidelines

KW - Oral mucositis

KW - Patient education

KW - Saline

KW - Sodium bicarbonate

UR - http://www.scopus.com/inward/record.url?scp=85068824989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068824989&partnerID=8YFLogxK

U2 - 10.1007/s00520-019-04848-4

DO - 10.1007/s00520-019-04848-4

M3 - Article

C2 - 31286232

AN - SCOPUS:85068824989

VL - 27

SP - 3949

EP - 3967

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 10

ER -